|
AHCYL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.770800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.446400E-01 |
| Normal-vs-Stage2 |
4.689400E-01 |
| Normal-vs-Stage3 |
5.051800E-01 |
| Normal-vs-Stage4 |
8.550200E-01 |
| Stage1-vs-Stage2 |
5.366200E-01 |
| Stage1-vs-Stage3 |
2.574400E-01 |
| Stage1-vs-Stage4 |
6.069600E-01 |
| Stage2-vs-Stage3 |
1.934630E-01 |
| Stage2-vs-Stage4 |
4.005800E-01 |
| Stage3-vs-Stage4 |
6.789600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.386200E-01 |
| Normal-vs-AfricanAmerican |
2.059000E-01 |
| Normal-vs-Asian |
6.246200E-01 |
| Caucasian-vs-AfricanAmerican |
1.229160E-01 |
| Caucasian-vs-Asian |
6.434000E-01 |
| AfricanAmerican-vs-Asian |
1.010180E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.244800E-01 |
| Normal-vs-Female |
8.061000E-01 |
| Male-vs-Female |
6.931600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.972200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.840000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.557800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.259370E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.445600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.922000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.528170E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.956600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.894770E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.568000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.271400E-01 |
| Classical-VS-Follicular |
1.786030E-01 |
| Classical-VS-Other |
1.740600E-01 |
| Classical-VS-Normal |
4.195600E-01 |
| Tall-VS-Follicular |
6.853800E-01 |
| Tall-VS-Other |
2.396200E-01 |
| Tall-VS-Normal |
9.542800E-01 |
| Follicular-VS-Other |
4.310400E-01 |
| Follicular-VS-Normal |
6.824400E-01 |
| Other-VS-Normal |
2.100800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.587800E-01 |
| Normal-vs-N1 |
1.219970E-01 |
| N0-vs-N1 |
1.932760E-01 |
|
|
